{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Diseases&page=15", "query": { "condition": "Multiple Diseases", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 12225, "total_pages": 1223, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Diseases&page=16&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Diseases&page=14&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T04:13:53.911Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04445519", "title": "Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "NCX 470 0.065% (initial phase of trial)", "type": "DRUG" }, { "name": "Latanoprost 0.005% (initial phase of trial)", "type": "DRUG" }, { "name": "NCX 470 0.1% (initial phase of trial)", "type": "DRUG" }, { "name": "NCX 470 0.1% (remainder of trial)", "type": "DRUG" }, { "name": "Latanoprost 0.005% (remainder of trial)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nicox Ophthalmics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 691, "start_date": "2020-06-01", "completion_date": "2022-09-16", "has_results": true, "last_update_posted_date": "2025-06-24", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04445519" }, { "nct_id": "NCT02947165", "title": "Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer", "Lung Cancer", "Hepatocellular Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Renal Cancer" ], "interventions": [ { "name": "NIS793", "type": "DRUG" }, { "name": "PDR001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2017-04-25", "completion_date": "2021-06-18", "has_results": false, "last_update_posted_date": "2022-01-31", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 2, "location_summary": "Nashville, Tennessee • Salt Lake City, Utah", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02947165" }, { "nct_id": "NCT01996436", "title": "The Intra-arterial Vasospasm Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cerebral Vasospasm" ], "interventions": [ { "name": "Nicardipine", "type": "DRUG" }, { "name": "Verapamil", "type": "DRUG" }, { "name": "Nicardipine + Verapamil + Nitroglycerin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peng Roc Chen, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 92, "start_date": "2016-08-29", "completion_date": "2024-08-12", "has_results": true, "last_update_posted_date": "2025-05-11", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 5, "location_summary": "New Haven, Connecticut • Manhasset, New York • Winston-Salem, North Carolina + 2 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Manhasset", "state": "New York" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Danville", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01996436" }, { "nct_id": "NCT03800134", "title": "A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Durvalumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 825, "start_date": "2018-12-06", "completion_date": "2028-09-11", "has_results": false, "last_update_posted_date": "2025-06-11", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Duarte, California • Orange, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03800134" }, { "nct_id": "NCT05198232", "title": "The Effects of Virtual Zumba® in Individuals With Developmental Disabilities", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Developmental Disability", "Autism Spectrum Disorder", "Down Syndrome", "Cerebral Palsy" ], "interventions": [ { "name": "Zumba High Tempo", "type": "BEHAVIORAL" }, { "name": "Zumba Low Tempo", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Auburn University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 57, "start_date": "2021-01-26", "completion_date": "2022-03-30", "has_results": false, "last_update_posted_date": "2022-05-05", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 1, "location_summary": "Auburn, Alabama", "locations": [ { "city": "Auburn", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05198232" }, { "nct_id": "NCT00645021", "title": "Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity", "Hepatic Insufficiency" ], "interventions": [ { "name": "CP-945,598", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2008-04", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2009-08-27", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 2, "location_summary": "Miami, Florida • Orlando, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00645021" }, { "nct_id": "NCT00547521", "title": "Phase IIIB Subcutaneous Abatacept Monotherapy Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis (RA)" ], "interventions": [ { "name": "abatacept", "type": "DRUG" }, { "name": "Methotrexate (MTX)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2007-12", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2015-03-23", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 15, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Palo Alto, California + 12 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Palm Harbor", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00547521" }, { "nct_id": "NCT05684016", "title": "Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis, Relapsing-Remitting" ], "interventions": [ { "name": "NeuroQuant", "type": "OTHER" }, { "name": "Automated Neuropsychological Assessment Matrices", "type": "OTHER" }, { "name": "EDSS", "type": "OTHER" }, { "name": "Physical Examination", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "George Washington University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 75, "start_date": "2013-12", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2023-01-13", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05684016" }, { "nct_id": "NCT00734578", "title": "Efficacy and Safety of SPD503 in Combination With Psychostimulants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "SPD503-AM", "type": "DRUG" }, { "name": "SPD503-PM", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 461, "start_date": "2008-09-02", "completion_date": "2009-12-10", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 61, "location_summary": "Dothan, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 53 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "El Centro", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00734578" }, { "nct_id": "NCT04073940", "title": "Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis, Relapsing-Remitting" ], "interventions": [ { "name": "Targeted Ballet Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Illinois at Urbana-Champaign", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 30, "start_date": "2019-08-29", "completion_date": "2021-01-15", "has_results": false, "last_update_posted_date": "2020-01-03", "last_synced_at": "2026-11-06T04:13:53.911Z", "location_count": 1, "location_summary": "Champaign, Illinois", "locations": [ { "city": "Champaign", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04073940" } ] }